Hayes Christopher G.'s Form 4 filing
Verrica Pharmaceuticals Inc. (VRCA) · filed Jul 23, 2024
- Accession no.
- 0001415889-24-019970
- Filed
- Jul 23, 2024
- Trade date
- Jul 22-23, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $153.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hayes Christopher G.CIK 0001805359 | Officer (CHIEF LEGAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | Common Stock | SSaleDisposed | −21,649 | $7.06 | −$152,841.94 | 141,577 | Direct | |
| Jul 23, 2024 | Common Stock | SSaleDisposed | −91 | $6.98 | −$635.18 | 141,486 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.